文献速递妇科肿瘤

LACC试验:早期宫颈癌开腹与微创根治性子宫切除术总生存期最终分析

LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
PubMed 文献 · J Clin Oncol · 2024-05-29

LACC试验最终分析比较早期宫颈癌开腹与微创根治性子宫切除术,中位随访4.5年。微创组4.5年无病生存率85.0%低于开腹组96%(HR 3.91,P<.001),总生存率90.6%对96.2%(HR 2.71,P=.007),微创手术复发率更高、总生存更差。

要点

  • 微创组4.5年无病生存率85.0%低于开腹组96%,HR 3.91(95%CI 2.02-7.58),P<.001。
  • 微创组4.5年总生存率90.6%低于开腹组96.2%,HR 2.71(95%CI 1.32-5.59),P=.007。
  • 鉴于微创手术复发率更高且总生存更差,作者认为开腹手术应作为标准治疗。

核心结论

  • 微创根治性子宫切除术与更高的复发率和更差的总生存相关,作者认为开腹手术应作为标准治疗。

研究设计与样本

  • LACC试验最终分析,共纳入631例早期宫颈癌患者,微创组319例、开腹组312例;实际接受微创手术289例(90.6%)、开腹手术274例(87.8%),随访4.5年。

主要发现

  • 4.5年无病生存率微创组85.0% vs 开腹组96%,差值-11.1(95%CI -15.8至-6.3),非劣效性检验P=.95。
  • 微创手术与开腹手术相比无病生存率更低,HR 3.91(95%CI 2.02-7.58),P<.001。
  • 4.5年总生存率微创组90.6% vs 开腹组96.2%,全因死亡HR 2.71(95%CI 1.32-5.59),P=.007。

关键数值与推荐

  • 样本量基于微创手术4.5年无病生存率90%和非劣效界值7.2%计算。

临床怎么用

  • 作者结论认为,鉴于微创手术复发率更高且总生存更差,开腹手术应作为标准治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.The aim of this study was to compare overall survival between open and minimally invasive radical hysterectomy with participants followed for 4.5 years. The primary objective was to evaluate whether minimally invasive surgery was noninferior in disease-free survival (DFS) to abdominal radical hysterectomy. Secondary outcomes included overall survival. Sample size was based on DFS of 90% at 4.5 years and 7.2% noninferiority margin for minimally invasive surgery. A total of 631 patients were enrolled: 319 assigned to minimally invasive and 312 to open surgery. Of these, 289 (90.6%) patients underwent minimally invasive surgery and 274 (87.8%) patients open surgery. At 4.5 years, DFS was 85.0% in the minimally invasive group and 96% in the open group (difference of -11.1; 95% CI, -15.8 to -6.3; P = .95 for noninferiority). Minimally invasive surgery was associated with lower rate of DFS compared with open surgery (hazard ratio [HR], 3.91 [95% CI, 2.02 to 7.58]; P < .001). Rate of overall survival at 4.5 years was 90.6% versus 96.2% for the minimally invasive and open surgery groups, respectively (HR for death of any cause = 2.71 [95% CI, 1.32 to 5.59]; P = .007). Given higher recurrence rate and worse overall survival with minimally invasive surgery, an open approach should be standard of care.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Ramirez PT, Robledo KP, Frumovitz M, et al. LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. J Clin Oncol. 2024. PMID: 38810208. doi:10.1200/JCO.23.02335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。